Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Stout JE and Floto RA Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others. 2012 Am. J. Respir. Crit. Care Med. pmid:23118083
Kanazawa S et al. Azithromycin and bronchiolitis obliterans. 2004 Am. J. Respir. Crit. Care Med. pmid:14982826
Tsai WC et al. Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. 2004 Am. J. Respir. Crit. Care Med. pmid:15361366
Jeong BH et al. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. 2015 Am. J. Respir. Crit. Care Med. pmid:25393520
Restrepo MI and Anzueto A Reply: Azithromycin: We're there! 2014 Am. J. Respir. Crit. Care Med. pmid:25360733
Hayes D et al. ABCA3 transporter deficiency. 2012 Am. J. Respir. Crit. Care Med. pmid:23071193
Albert RK et al. Azithromycin: We're there! 2014 Am. J. Respir. Crit. Care Med. pmid:25360732
Saiman L et al. Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis. 2005 Am. J. Respir. Crit. Care Med. pmid:16040785
Choi GE et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. 2012 Am. J. Respir. Crit. Care Med. pmid:22878281
Binder AM et al. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. 2013 Am. J. Respir. Crit. Care Med. pmid:23927602
Hodge S et al. Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. 2008 Am. J. Respir. Crit. Care Med. pmid:18420960
O'Beirne SL et al. Severe Cavitary, Fistulating Mycobacterium avium-intracellulare Complex Disease in an Immunocompetent Host. 2015 Am. J. Respir. Crit. Care Med. pmid:26244303
Angel LF et al. Azithromycin in bronchiolitis obliterans: is the evidence strong enough? 2006 Am. J. Respir. Crit. Care Med. pmid:16467178
Mertens V et al. Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin. 2011 Am. J. Transplant. pmid:21272237
Glanville AR CLAD: does the Emperor have new clothes? 2014 Am. J. Transplant. pmid:25394597
Vos R et al. Azithromycin and the treatment of lymphocytic airway inflammation after lung transplantation. 2014 Am. J. Transplant. pmid:25394537
Verleden SE et al. Lymphocytic bronchiolitis after lung transplantation is associated with daily changes in air pollution. 2012 Am. J. Transplant. pmid:22682332
Vanaudenaerde BM et al. Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. 2007 Am. J. Transplant. pmid:17061983
Greer M et al. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. 2013 Am. J. Transplant. pmid:23406373
Robertson AG et al. Targeting allograft injury and inflammation in the management of post-lung transplant bronchiolitis obliterans syndrome. 2009 Am. J. Transplant. pmid:19459806
Ruttens D et al. Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial. 2016 Am. J. Transplant. pmid:26372728
Amsden GW et al. Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers. 2007 Am. J. Trop. Med. Hyg. pmid:17556628
O'Brien KS et al. Mass Azithromycin and Malaria Parasitemia in Niger: Results from a Community-Randomized Trial. 2017 Am. J. Trop. Med. Hyg. pmid:28722569
Stoney RJ et al. Travelers' Diarrhea and Other Gastrointestinal Symptoms Among Boston-Area International Travelers. 2017 Am. J. Trop. Med. Hyg. pmid:28719282
Miller RS et al. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. 2006 Am. J. Trop. Med. Hyg. pmid:16525097
Cook JA et al. Lack of a pharmacokinetic interaction between azithromycin and chloroquine. 2006 Am. J. Trop. Med. Hyg. pmid:16525098
Chetchotisakd P et al. Maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline. 2001 Jan-Feb Am. J. Trop. Med. Hyg. pmid:11425157
Chi KH et al. Molecular differentiation of Treponema pallidum subspecies in skin ulceration clinically suspected as yaws in Vanuatu using real-time multiplex PCR and serological methods. 2015 Am. J. Trop. Med. Hyg. pmid:25404075
Gingras BA and Jensen JB Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. 1992 Am. J. Trop. Med. Hyg. pmid:1326232
Gao D et al. Optimal seasonal timing of oral azithromycin for malaria. 2014 Am. J. Trop. Med. Hyg. pmid:25223942
Rosenthal PJ Azithromycin for Malaria? 2016 Am. J. Trop. Med. Hyg. pmid:27215296
Layegh P et al. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. 2007 Am. J. Trop. Med. Hyg. pmid:17620637
Katanami Y et al. Six Cases of Paratyphoid Fever Due to Salmonella Paratyphi A in Travelers Returning from Myanmar Between July 2014 and August 2015. 2016 Am. J. Trop. Med. Hyg. pmid:27352874
Kumaresan JA and Mecaskey JW The global elimination of blinding trachoma: progress and promise. 2003 Am. J. Trop. Med. Hyg. pmid:14692677
Phong NC et al. In Vivo Efficacy and Tolerability of Artesunate-Azithromycin for the Treatment of Falciparum Malaria in Vietnam. 2016 Am. J. Trop. Med. Hyg. pmid:27215294
Yelenich-Huss MJ et al. Ozena in Immigrants of Differing Backgrounds. 2016 Am. J. Trop. Med. Hyg. pmid:27114295
Krolewiecki A et al. Activity of azithromycin against Leishmania major in vitro and in vivo. 2002 Am. J. Trop. Med. Hyg. pmid:12408666
Luntamo M et al. Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial. 2010 Am. J. Trop. Med. Hyg. pmid:21118924
de Oliveira-Silva F et al. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi. 2008 Am. J. Trop. Med. Hyg. pmid:18458308
Ayele B et al. Adverse events after mass azithromycin treatments for trachoma in Ethiopia. 2011 Am. J. Trop. Med. Hyg. pmid:21813850
Gebre T et al. Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia. 2011 Am. J. Trop. Med. Hyg. pmid:21896815
Gingras BA and Jensen JB Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. 1993 Am. J. Trop. Med. Hyg. pmid:8394660
Å majs D et al. Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains? 2015 Am. J. Trop. Med. Hyg. pmid:26217043
Shih CM and Wang CC Ability of azithromycin in combination with quinine for the elimination of babesial infection in humans. 1998 Am. J. Trop. Med. Hyg. pmid:9790419
Krolewiecki AJ et al. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. 2007 Am. J. Trop. Med. Hyg. pmid:17978064
Richards FO et al. No depletion of Wolbachia from Onchocerca volvulus after a short course of rifampin and/or azithromycin. 2007 Am. J. Trop. Med. Hyg. pmid:17984346
Fossa AA et al. Azithromycin/chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized guinea pig. 2007 Am. J. Trop. Med. Hyg. pmid:17984356
Keenan JD et al. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma. 2010 Am. J. Trop. Med. Hyg. pmid:20207878
Coles CL et al. Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children. 2011 Am. J. Trop. Med. Hyg. pmid:21976574
Dunne MW et al. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India. 2005 Am. J. Trop. Med. Hyg. pmid:16354821